| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 7.91 mm | 7.91 mm | 7.91 mm | 7.91 mm | 7.91 mm | 7.91 mm |
| Cash burn (monthly) | (no burn) | 1.45 mm | 3.33 mm | 5.53 mm | (no burn) | 3.84 mm |
| Cash used (since last report) | n/a | 25.86 mm | 59.31 mm | 98.42 mm | n/a | 68.29 mm |
| Cash remaining | n/a | -17.95 mm | -51.40 mm | -90.51 mm | n/a | -60.38 mm |
| Runway (months of cash) | n/a | -12.4 | -15.4 | -16.4 | n/a | -15.7 |
| 13F holders | Current |
|---|---|
| Total holders | 4 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 5.15 mm |
| Total shares | 33.85 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| SSD2 | 13.41 mm | $4.10 mm |
| HPSO SPV | 12.18 mm | $0.00 |
| CMS Medical Venture Investment | 4.50 mm | $0.00 |
| Pacific Investment Management | 3.76 mm | $1.05 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 Sep 23 | PureTech Health | Convertible Note Common Stock | Buy | Acquire P | Yes | No | 1500000 | - | 1.50 mm | - |
